Skip to main content
  • Main menu
  • User menu
  • Search
  • English ▼
    • English
    • Afrikaans
    • Albanian
    • Amharic
    • Arabic
    • Armenian
    • Azerbaijani
    • Basque
    • Belarusian
    • Bengali
    • Bosnian
    • Bulgarian
    • Catalan
    • Cebuano
    • Chichewa
    • Chinese (Simplified)
    • Chinese (Traditional)
    • Corsican
    • Croatian
    • Czech
    • Danish
    • Dutch
    • Esperanto
    • Estonian
    • Filipino
    • Finnish
    • French
    • Frisian
    • Galician
    • Georgian
    • German
    • Greek
    • Gujarati
    • Haitian Creole
    • Hausa
    • Hawaiian
    • Hebrew
    • Hindi
    • Hmong
    • Hungarian
    • Icelandic
    • Igbo
    • Indonesian
    • Irish
    • Italian
    • Japanese
    • Javanese
    • Kannada
    • Kazakh
    • Khmer
    • Korean
    • Kurdish (Kurmanji)
    • Kyrgyz
    • Lao
    • Latin
    • Latvian
    • Lithuanian
    • Luxembourgish
    • Macedonian
    • Malagasy
    • Malay
    • Malayalam
    • Maltese
    • Maori
    • Marathi
    • Mongolian
    • Myanmar (Burmese)
    • Nepali
    • Norwegian
    • Pashto
    • Persian
    • Polish
    • Portuguese
    • Punjabi
    • Romanian
    • Russian
    • Samoan
    • Scottish Gaelic
    • Serbian
    • Sesotho
    • Shona
    • Sindhi
    • Sinhala
    • Slovak
    • Slovenian
    • Somali
    • Spanish
    • Sudanese
    • Swahili
    • Swedish
    • Tajik
    • Tamil
    • Telugu
    • Thai
    • Turkish
    • Ukrainian
    • Urdu
    • Uzbek
    • Vietnamese
    • Welsh
    • Xhosa
    • Yiddish
    • Yoruba
    • Zulu

Main menu

  • Home
  • Content
    • Current
      • JNMT Supplement
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine Technology
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine Technology

Advanced Search

English ▼
  • English
  • Afrikaans
  • Albanian
  • Amharic
  • Arabic
  • Armenian
  • Azerbaijani
  • Basque
  • Belarusian
  • Bengali
  • Bosnian
  • Bulgarian
  • Catalan
  • Cebuano
  • Chichewa
  • Chinese (Simplified)
  • Chinese (Traditional)
  • Corsican
  • Croatian
  • Czech
  • Danish
  • Dutch
  • Esperanto
  • Estonian
  • Filipino
  • Finnish
  • French
  • Frisian
  • Galician
  • Georgian
  • German
  • Greek
  • Gujarati
  • Haitian Creole
  • Hausa
  • Hawaiian
  • Hebrew
  • Hindi
  • Hmong
  • Hungarian
  • Icelandic
  • Igbo
  • Indonesian
  • Irish
  • Italian
  • Japanese
  • Javanese
  • Kannada
  • Kazakh
  • Khmer
  • Korean
  • Kurdish (Kurmanji)
  • Kyrgyz
  • Lao
  • Latin
  • Latvian
  • Lithuanian
  • Luxembourgish
  • Macedonian
  • Malagasy
  • Malay
  • Malayalam
  • Maltese
  • Maori
  • Marathi
  • Mongolian
  • Myanmar (Burmese)
  • Nepali
  • Norwegian
  • Pashto
  • Persian
  • Polish
  • Portuguese
  • Punjabi
  • Romanian
  • Russian
  • Samoan
  • Scottish Gaelic
  • Serbian
  • Sesotho
  • Shona
  • Sindhi
  • Sinhala
  • Slovak
  • Slovenian
  • Somali
  • Spanish
  • Sudanese
  • Swahili
  • Swedish
  • Tajik
  • Tamil
  • Telugu
  • Thai
  • Turkish
  • Ukrainian
  • Urdu
  • Uzbek
  • Vietnamese
  • Welsh
  • Xhosa
  • Yiddish
  • Yoruba
  • Zulu
  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Watch or Listen to JNMT Podcast
  • Visit SNMMI on Facebook
  • Join SNMMI on LinkedIn
  • Follow SNMMI on Twitter
  • Subscribe to JNMT RSS feeds
OtherBrief Communication

Peptide Receptor Radionuclide Therapy in Merkel Cell Carcinoma: A Comprehensive Review

Emran Askari, Soroush Zarehparvar Moghadam, Damian Wild, Ebrahim Delpassand, Sergio Baldari, Bernhard Nilica, Philipp E. Hartrampf, Grace Kong, Chiara Maria Grana, Martin Alexander Walter, Francesca Capoccetti, Pashtoon Murtaza Kasi and Jonathan Strosberg
Journal of Nuclear Medicine Technology October 2022, jnmt.122.264904; DOI: https://doi.org/10.2967/jnmt.122.264904
Emran Askari
1 Nuclear Medicine Research Center, Mashhad University of Medical Sciences, Iran, Islamic Republic of;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Soroush Zarehparvar Moghadam
1 Nuclear Medicine Research Center, Mashhad University of Medical Sciences, Iran, Islamic Republic of;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Damian Wild
2 ENETS Center of Excellence, University Hospital Basel, Radiology & Nuclear Medicine;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ebrahim Delpassand
3 Department of Clinical Nuclear Medicine, Excel Diagnostics Imaging Clinic, United States;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sergio Baldari
4 Department of Biomedical and Dental Sciences and of Morpho-Functional Imaging, Nuclear Medicine Unit, University of Messina, Italy;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bernhard Nilica
5 Department of Nuclear Medicine, Medical University Innsbruck, Austria;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Philipp E. Hartrampf
6 Department of Nuclear Medicine, University Hospital Würzburg, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Grace Kong
7 Sir Peter MacCallum Department of Oncology, Peter MacCallum Cancer Centre, Australia;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chiara Maria Grana
8 Division of Nuclear Medicine, IEO, European Institute of Oncology IRCCS, Italy;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martin Alexander Walter
9 Nuclear Medicine and Molecular Division, Geneva Medical Hospital, Switzerland;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Francesca Capoccetti
10 UOC Nuclear Medicine-PET Center-Single Regional Center for Radiometabolic Therapy, Department of Radiological Diagnosis and Services, ASUR Marche-AV3, Italy;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pashtoon Murtaza Kasi
11 Weill Cornell Medicine, NewYork Presbyterian Hospital, Meyer Cancer Center, Englander Institute of Precision Medicine, United States;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jonathan Strosberg
12 Gastrointestinal Department/Neuroendocrine Tumor Division, Moffitt Cancer Center, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Article Information

jnmt.122.264904
DOI 
https://doi.org/10.2967/jnmt.122.264904
PubMed 
36195446

Published By 
Society of Nuclear Medicine
Print ISSN 
0091-4916
Online ISSN 
1535-5675
History 
  • Published online October 4, 2022.

Article Versions

  • You are currently viewing a previous version of this article (October 4, 2022 - 14:55).
  • View the most recent version of this article
Copyright & Usage 
Copyright © 2022 by the Society of Nuclear Medicine and Molecular Imaging, Inc.

Author Information

  1. Emran Askari1,
  2. Soroush Zarehparvar Moghadam1,
  3. Damian Wild2,
  4. Ebrahim Delpassand3,
  5. Sergio Baldari4,
  6. Bernhard Nilica5,
  7. Philipp E. Hartrampf6,
  8. Grace Kong7,
  9. Chiara Maria Grana8,
  10. Martin Alexander Walter9,
  11. Francesca Capoccetti10,
  12. Pashtoon Murtaza Kasi11 and
  13. Jonathan Strosberg12
  1. 1 Nuclear Medicine Research Center, Mashhad University of Medical Sciences, Iran, Islamic Republic of;
  2. 2 ENETS Center of Excellence, University Hospital Basel, Radiology & Nuclear Medicine;
  3. 3 Department of Clinical Nuclear Medicine, Excel Diagnostics Imaging Clinic, United States;
  4. 4 Department of Biomedical and Dental Sciences and of Morpho-Functional Imaging, Nuclear Medicine Unit, University of Messina, Italy;
  5. 5 Department of Nuclear Medicine, Medical University Innsbruck, Austria;
  6. 6 Department of Nuclear Medicine, University Hospital Würzburg, Germany;
  7. 7 Sir Peter MacCallum Department of Oncology, Peter MacCallum Cancer Centre, Australia;
  8. 8 Division of Nuclear Medicine, IEO, European Institute of Oncology IRCCS, Italy;
  9. 9 Nuclear Medicine and Molecular Division, Geneva Medical Hospital, Switzerland;
  10. 10 UOC Nuclear Medicine-PET Center-Single Regional Center for Radiometabolic Therapy, Department of Radiological Diagnosis and Services, ASUR Marche-AV3, Italy;
  11. 11 Weill Cornell Medicine, NewYork Presbyterian Hospital, Meyer Cancer Center, Englander Institute of Precision Medicine, United States;
  12. 12 Gastrointestinal Department/Neuroendocrine Tumor Division, Moffitt Cancer Center, United States
  1. For correspondence or reprints contact: Jonathan Strosberg, Gastrointestinal Department/Neuroendocrine Tumor Division, Moffitt Cancer Center, Tampa, Florida 33612, United States. E-mail: jonathan.strosberg@moffitt.org

Statistics from Altmetric.com

Article has an altmetric score of 20

See more details

Posted by 36 X users
4 readers on Mendeley

Cited By...

  • 12 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • The Evolving Treatment Landscape of Merkel Cell Carcinoma
    Neha Singh, Erin M. McClure, Tomoko Akaike, Song Y. Park, Emily T. Huynh, Peter H. Goff, Paul Nghiem
    Current Treatment Options in Oncology 2023 24 9
  • Alpha and Beta Radiation for Theragnostics
    Hong Song, George Sgouros
    PET Clinics 2024 19 3
  • Merkel cell carcinoma: a review of clinical management with focus on Asian patients
    Eiji Nakano, Dai Ogata, Kenjiro Namikawa, Naoya Yamazaki
    Japanese Journal of Clinical Oncology 2023 53 8
  • Merkel cell carcinoma: updates in tumor biology, emerging therapies, and preclinical models
    Elisabeth A. Pedersen, Monique E. Verhaegen, Mallory K. Joseph, Kelly L. Harms, Paul W. Harms
    Frontiers in Oncology 2024 14
  • Radiolabeled Somatostatin Analogs for Cancer Imaging
    Aamir K. Nazar, Sandip Basu
    Seminars in Nuclear Medicine 2024 54 6
  • Advancing Treatment Options for Merkel Cell Carcinoma: A Review of Tumor-Targeted Therapies
    Helena M. Nammour, Karla Madrigal, Caroline T. Starling, Hung Q. Doan
    International Journal of Molecular Sciences 2024 25 20
  • Current and preclinical treatment options for Merkel cell carcinoma
    Büke Celikdemir, Roland Houben, Thibault Kervarrec, Mahtab Samimi, David Schrama
    Expert Opinion on Biological Therapy 2023 23 10
  • Somatostatin receptor expression in Merkel cell carcinoma: correlation with clinical data
    Klaus W. Fagerstedt, Tiina Vesterinen, Helena Leijon, Harri Sihto, Tom Böhling, Johanna Arola
    Acta Oncologica 2023 62 9
  • Peptide receptor radionuclide therapy with somatostatin analogs beyond gastroenteropancreatic neuroendocrine tumors
    Giulia Santo, Gianpaolo di Santo, Francesco Cicone, Irene Virgolini
    Journal of Neuroendocrinology 2025 37 3
  • SSTR Antagonists as Theranostic Option in Merkel Cell Carcinoma
    Malte Kircher, Adriana Amerein, Mareike Augustin, Nic G. Reitsam, Johanna S. Enke, Marianne Patt, Georgine Wienand, Ralph A. Bundschuh, Christian H. Pfob, Constantin Lapa, Alexander Dierks
    Journal of Nuclear Medicine 2024 65 6

Article usage

Article usage: October 2022 to April 2025

AbstractFullPdf
AbstractFullPdf
Oct 20221334018
Nov 202234602
Dec 202216100
Jan 202318101
Feb 202314502
Mar 20236732611
Apr 2023448149
May 202331265
Jun 202316386
Jul 202315165
Aug 202319189
Sep 202315921
Oct 202316112
Nov 202317839
Dec 2023120314
Jan 20241011818
Feb 2024493123
Mar 2024362618
Apr 2024334531
May 20243812443
Jun 2024375434
Jul 2024357041
Aug 2024298430
Sep 2024328445
Oct 2024497432
Nov 2024353816
Dec 202483214
Jan 2025194725
Feb 2025286226
Mar 2025228835
Apr 2025238455
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine Technology: 53 (1)
Journal of Nuclear Medicine Technology
Vol. 53, Issue 1
March 1, 2025
  • Table of Contents
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Download PDF
Article Alerts
Email Article
Citation Tools
Share
Peptide Receptor Radionuclide Therapy in Merkel Cell Carcinoma: A Comprehensive Review
Emran Askari, Soroush Zarehparvar Moghadam, Damian Wild, Ebrahim Delpassand, Sergio Baldari, Bernhard Nilica, Philipp E. Hartrampf, Grace Kong, Chiara Maria Grana, Martin Alexander Walter, Francesca Capoccetti, Pashtoon Murtaza Kasi, Jonathan Strosberg
Journal of Nuclear Medicine Technology Oct 2022, jnmt.122.264904; DOI: 10.2967/jnmt.122.264904
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • SSTR Antagonists as Theranostic Option in Merkel Cell Carcinoma
  • Google Scholar

Similar Articles

Keywords

  • Neuroendocrine
  • Oncology: Endocrine
  • Radionuclide Therapy
  • Lu-177
  • Merkel cell carcinoma
  • PRRT
  • SSTR
  • theranostics
SNMMI

© 2025 SNMMI

Powered by HighWire
Alerts for this Article
Sign In to Email Alerts with your Email Address
Email this Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Peptide Receptor Radionuclide Therapy in Merkel Cell Carcinoma: A Comprehensive Review
(Your Name) has sent you a message from Journal of Nuclear Medicine Technology
(Your Name) thought you would like to see the Journal of Nuclear Medicine Technology web site.
Citation Tools
Peptide Receptor Radionuclide Therapy in Merkel Cell Carcinoma: A Comprehensive Review
Emran Askari, Soroush Zarehparvar Moghadam, Damian Wild, Ebrahim Delpassand, Sergio Baldari, Bernhard Nilica, Philipp E. Hartrampf, Grace Kong, Chiara Maria Grana, Martin Alexander Walter, Francesca Capoccetti, Pashtoon Murtaza Kasi, Jonathan Strosberg
Journal of Nuclear Medicine Technology Oct 2022, jnmt.122.264904; DOI: 10.2967/jnmt.122.264904

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

We use cookies on this site to enhance your user experience

By clicking any link on this page you are giving your consent for us to set cookies.